KR20090100136A - 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의예방 또는 치료용 조성물 - Google Patents
폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의예방 또는 치료용 조성물 Download PDFInfo
- Publication number
- KR20090100136A KR20090100136A KR1020080025559A KR20080025559A KR20090100136A KR 20090100136 A KR20090100136 A KR 20090100136A KR 1020080025559 A KR1020080025559 A KR 1020080025559A KR 20080025559 A KR20080025559 A KR 20080025559A KR 20090100136 A KR20090100136 A KR 20090100136A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- allergic diseases
- preventing
- asthma
- cells
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
- 폴리감마글루탐산 및 약제학적으로 허용되는 담체를 포함하는 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물.
- 제 1 항에 있어서, 폴리감마글루탐산의 분자량은 1~2000kDa 인 것을 특징으로 하는 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물.
- 제 1 항 또는 제 2 항에 있어서, 폴리감마글루탐산은 IL-4 또는 IL-13의 발현을 억제하는 것을 특징으로 하는 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물.
- 제 1 항 또는 제 2 항에 있어서, 질환은 Th 매개성 질환인 것을 특징으로 하는 천식 또는 알레르기성 질환의 예방 및 치료용 조성물.
- 제 1 항 또는 제 2 항에 있어서, 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물은 경구용인 것을 특징으로 하는 천식 또는 알레르기성 질환의 예방 및 치료용 조성물.
- 제 1 항 또는 제 2 항에 있어서, 천식 또는 알레르기성 질환의 예방 또는 치 료용 조성물은 비경구용인 것을 특징으로 하는 천식 또는 알레르기성 질환의 예방 및 치료용 조성물.
- 제 6 항에 있어서, 제 1 항 또는 제 2 항에 있어서, 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물은 흡입용인 것을 특징으로 하는 천식 또는 알레르기성 질환의 예방 및 치료용 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080025559A KR100992551B1 (ko) | 2008-03-19 | 2008-03-19 | 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의예방 또는 치료용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080025559A KR100992551B1 (ko) | 2008-03-19 | 2008-03-19 | 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의예방 또는 치료용 조성물 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100084024A Division KR20100105519A (ko) | 2010-08-30 | 2010-08-30 | 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090100136A true KR20090100136A (ko) | 2009-09-23 |
KR100992551B1 KR100992551B1 (ko) | 2010-11-08 |
Family
ID=41358546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080025559A KR100992551B1 (ko) | 2008-03-19 | 2008-03-19 | 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의예방 또는 치료용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100992551B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014193132A1 (ko) * | 2013-05-27 | 2014-12-04 | 주식회사 바이오리더스 | 폴리감마글루탐산을 함유하는 점액 분산 또는 수화용 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100475406B1 (ko) * | 2003-12-12 | 2005-03-14 | 주식회사 바이오리더스 | 폴리감마글루탐산을 함유하는 면역증강용 조성물 |
US20090156480A1 (en) | 2005-08-25 | 2009-06-18 | Mitsuru Akashi | Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein |
-
2008
- 2008-03-19 KR KR1020080025559A patent/KR100992551B1/ko active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014193132A1 (ko) * | 2013-05-27 | 2014-12-04 | 주식회사 바이오리더스 | 폴리감마글루탐산을 함유하는 점액 분산 또는 수화용 조성물 |
KR20140139262A (ko) * | 2013-05-27 | 2014-12-05 | 주식회사 바이오리더스 | 폴리감마글루탐산을 함유하는 점액 분산 또는 수화용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR100992551B1 (ko) | 2010-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
El Gazzar et al. | Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation | |
El Gazzar et al. | Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma | |
Wang et al. | LPS-induced indoleamine 2, 3-dioxygenase is regulated in an interferon-γ-independent manner by a JNK signaling pathway in primary murine microglia | |
Amri et al. | Involvement of IL-10 and IL-4 in evasion strategies of Echinococcus granulosus to host immune response | |
Neilsen et al. | Interleukin‐13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils | |
Shahzad et al. | Black seed oil ameliorates allergic airway inflammation by inhibiting T-cell proliferation in rats | |
Shimbori et al. | Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice | |
JP2003514869A (ja) | アレルギー性疾患の処置のための組成物および方法 | |
Akdis et al. | Regulatory effects of histamine and histamine receptor expression in human allergic immune responses | |
Secor Jr et al. | Bromelain limits airway inflammation in an ovalbumin-induced murine model of established asthma | |
Yuk et al. | Effects of astilbic acid on airway hyperresponsiveness and inflammation in a mouse model of allergic asthma | |
KR20130031229A (ko) | 메포민을 포함하는 자가면역질환 예방 및 치료용 조성물 | |
Pender et al. | Systemic administration of the chemokine macrophage inflammatory protein 1α exacerbates inflammatory bowel disease in a mouse model | |
CN103200955A (zh) | 包含肽和病毒神经氨酸酶抑制剂的组合物 | |
Tsuchiya et al. | EGF receptor activation during allergic sensitization affects IL‐6‐induced T‐cell influx to airways in a rat model of asthma | |
Kim et al. | Inhibitory effect on immunoglobulin E production in vivo and in vitro by Siegesbeckia glabrescens | |
Denis et al. | Chronic intranasal administration of mould spores or extracts to unsensitized mice leads to lung allergic inflammation, hyper‐reactivity and remodelling | |
Lee et al. | Tiarellic acid attenuates airway hyperresponsiveness and inflammation in a murine model of allergic asthma | |
Kim et al. | Asiasari radix inhibits immunoglobulin E production on experimental models in vitro and in vivo | |
KR100992551B1 (ko) | 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의예방 또는 치료용 조성물 | |
Tazaki et al. | Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor β2 chain expression in patients with allergic asthma | |
US20020061841A1 (en) | Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils | |
KR20100105519A (ko) | 폴리감마글루탐산을 포함하는 천식 또는 알레르기성 질환의 예방 또는 치료용 조성물 | |
CN114732814A (zh) | 尿石素a在防治过敏性鼻炎及过敏性哮喘中的应用 | |
CN105853417B (zh) | 乌头碱在治疗红斑狼疮中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131002 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140923 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20151012 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161101 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170921 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181001 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190923 Year of fee payment: 10 |